OVERVIEW

Drug Discovery Biology & Bioinformatics Strategy Meeting Europe 2024 is organized by Proventa International and will be held on Oct 22, 2024 at Crowne Plaza London Docklands, an IHG Hotel, London, England, United Kingdom.

Description:
Drug Discovery Biology & Bioinformatics Strategy Meeting Europe of Proventa International is an event where key decision-makers from biotech and pharmaceutical companies, academia, and regulatory agencies gather to discuss the latest trends and strategies in drug discovery biology. This meeting is designed to facilitate collaboration, knowledge sharing, and networking among the participants, with a focus on identifying innovative approaches for drug discovery, exploring new technologies and methods, and addressing challenges in drug development. The meeting includes interactive panel discussions, case studies, and roundtable sessions where participants can share their experiences, insights, and best practices. Overall, the Drug Discovery Biology Strategy Meeting aims to accelerate drug discovery and development by fostering collaboration and innovation among the industry's top leaders.

Additional details will be posted as soon as information is available.

KEY DATES

Event Start Date
22 Oct, 2024
Event Start Date
Event End Date
22 Oct, 2024
Event End Date
Credits
  • 10 Contact Hours
  • TARGET AUDIENCE

    Other Health ProfessionalsOther Health Scientists

    SPECIALITIES

    BiotechnologyBioinformaticsResearch and Clinical Research

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationCrowne Plaza London Docklands, an IHG Hotel
    Royal Victoria Dock, Western Gateway

    RELATED CONFERENCES & LIVE WEBINARS

    Jul 23 - 24, 2026 | Vienna, Wien, AT

    Research and Clinical Research
    More actions
    AT€350

    Oct 29 - 30, 2026 | Orlando, Florida, USA

    Oncology
    More actions
    US$235
    Featured Conference
    By Global Regenerative Academy (GRA)

    Nov 20 - 22, 2026 | Paphos, Paphos, CY

    Research and Clinical Research
    14 ECMECs
    More actions
    US$149